PureTech Health reports positive Phase 1b data for LYT-200 in MDS and AML
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Ondine Biomedical abstracts selected for 2026 World Congress on Infectious Diseases
hVIVO secures Phase III human challenge trial contract with ILiAD Biotechnologies
FDA expands approval of Sanofi's Tzield for early-stage type 1 diabetes in young children
Inhibrx provides clinical update on ozekibart (INBRX-109) for colorectal cancer treatment
Lytix reports phase II results showing durable responses in advanced melanoma
Rznomics reports RZ-001 interim clinical data in hepatocellular carcinoma at AACR 2026
Akeso presents positive Phase II results from cadonilimab combination study at AACR 2026
LENZ Therapeutics advances VIZZ regulatory expansion with UK submission for presbyopia treatment
GSK secures China approval for Blenrep in relapsed multiple myeloma
Sanofi's Nuvaxovid demonstrates superior tolerability to Moderna's mNEXSPIKE in phase 4 study
AstraZeneca reports third positive Phase III trial for tozorakimab in COPD
TheraCryf advances Ox-1 programme to clinical stage following successful GMP manufacture